Biosimilars Market Research Reports & Industry Analysis

Biosimilars (otherwise termed follow-on-biologics, or FOBs for short) stand for the versions of biopharmaceuticals, which have the resembling but not identical parent molecule, and are created either by living organisms or from living micro-organisms by way of rDNA (recombinant DNA) or supervised gene expression technologies. The approval of Biosimilars occurs via strictly defined regulatory paths based on whether FOBs have shown comparability with their reference substance.

The worldwide Biosimilars Market is anticipated to surpass a EUR 14.9bn mark by end 2018. The major drivers encompass cost efficiency of biosimilars versus their high-priced analogues, the enlarging thirst for biotechnology drugs, imminent biotech drugs’ patent expiries, the planet’s aging population, and the rising frequency of critical illnesses. The illustrious actors on the global Biosimilars stage encompass Biocon, Intas Biopharmaceuticals, Cipla, Biopartners, Hospira, Wockhardt, Teva Pharmaceutical Industries, Sandoz International, amidst others.

The Catalogue’s research reports offer world, region and nation-wise analyses of the Biosimilars Market development over various time periods. The researches are lavish with discussions of the Biosimilars Industry growth rate, structure and capacity. The market trends, growth obstacles/stimulators, key products and those in R&D stage, and more issues are studied in the reports. Additionally, the research reports indicate and profile the leading players and hoped-for entrants, and offer market projections and forecasts.

Found 156 publications
Global Biosimilars Market 2018-2024 US$ 2,750.00

... the growth this market to a large extent. Market Analysis: The “Global Biosimilars Market” is estimated to witness a CAGR of 57.03% during the forecast period 2018–2024. The market is analyzed based on three ...

Mar, 2018 120 pages
Biosimilars: Global Markets US$ 3,950.00

... emerging framework in regulated markets, as well as comparisons of biosimilar guidelines in Europe, the U.S., Japan, Canada, as well the guidelines developed by the - World Health Organization Technology trends and ...

Mar, 2018 340 pages
Charting the Global Biosimialr pipeline US$ 745.00

... and many other questions can be found in Charting the Global Biosimilars Pipeline. This comprehensive report provides the most detailed evaluation ... biosimilar companies Biosimilar pipeline by product BIOSIMILAR PIPELINE BY PRODUCT Each biosimilar monograph utilises well-structured tables and charts to provide ...

Jan, 2018
Biosimilars-United States Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the United States Biosimilars market as: United States Biosimilars Market ...

Feb, 2018 140 pages
Biosimilars-South America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the South America Biosimilars market as: South America Biosimilars Market ...

Feb, 2018 135 pages
Biosimilars-North America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the North America Biosimilars market as: North America Biosimilars Market ...

Feb, 2018 132 pages
Biosimilars-India Market Status and Trend Report 2013-2023 US$ 2,980.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the India Biosimilars market as: India Biosimilars Market: Regional ...

Feb, 2018 144 pages
Biosimilars-Global Market Status and Trend Report 2013-2023 US$ 2,480.00

Report Summary Biosimilars-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilars industry, standing on the readers’ perspective, delivering detailed market data and penetrating ...

Feb, 2018 153 pages
Biosimilars-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data US$ 3,680.00

... Summary Biosimilars-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biosimilars industry, standing on the readers’ perspective, delivering detailed market data in Global ...

Feb, 2018 138 pages
Biosimilars-Europe Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the Europe Biosimilars market as: Europe Biosimilars Market: Regional ...

Feb, 2018 137 pages
Biosimilars-EMEA Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Biosimilars-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilars industry, standing on the readers’ perspective, delivering detailed market data and penetrating ...

Feb, 2018 146 pages
Biosimilars-China Market Status and Trend Report 2013-2023 US$ 2,980.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the China Biosimilars market as: China Biosimilars Market: Regional ...

Feb, 2018 141 pages
Biosimilars-Asia Pacific Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Biosimilars market as: Asia Pacific Biosimilars Market ...

Feb, 2018 150 pages
Biosimilars Market, 2012 to 2023 US$ 4,400.00

... , Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Global Biosimilars Market Report Description: Global biosimilars market report gives a comprehensive outlook on biosimilars products across the ...

Jan, 2018 192 pages
Hereceptin Biosimilar-United States Market Status and Trend Report 2013-2023 US$ 3,480.00

... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the United States Hereceptin Biosimilar market as: United States ...

Dec, 2017 133 pages
Hereceptin Biosimilar-South America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the South America Hereceptin Biosimilar market as: South America ...

Dec, 2017 159 pages
Hereceptin Biosimilar-North America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the North America Hereceptin Biosimilar market as: North America ...

Dec, 2017 154 pages
Hereceptin Biosimilar-India Market Status and Trend Report 2013-2023 US$ 2,980.00

... Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the India Hereceptin Biosimilar market as: India Hereceptin Biosimilar Market ...

Dec, 2017 146 pages
Hereceptin Biosimilar-Global Market Status and Trend Report 2013-2023 US$ 2,480.00

Report Summary Hereceptin Biosimilar-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Hereceptin Biosimilar industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 160 pages
Hereceptin Biosimilar-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data US$ 3,680.00

... Hereceptin Biosimilar-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Hereceptin Biosimilar industry, standing on the readers’ perspective, delivering detailed market data in Global ...

Dec, 2017 134 pages
Hereceptin Biosimilar-Europe Market Status and Trend Report 2013-2023 US$ 3,480.00

... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the Europe Hereceptin Biosimilar market as: Europe Hereceptin ...

Dec, 2017 135 pages
Hereceptin Biosimilar-EMEA Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Hereceptin Biosimilar-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Hereceptin Biosimilar industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 148 pages
Hereceptin Biosimilar-China Market Status and Trend Report 2013-2023 US$ 2,980.00

... Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the China Hereceptin Biosimilar market as: China Hereceptin Biosimilar Market ...

Dec, 2017 141 pages
Hereceptin Biosimilar-Asia Pacific Market Status and Trend Report 2013-2023 US$ 3,480.00

... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Hereceptin Biosimilar market as: Asia Pacific ...

Dec, 2017 137 pages
Biosimilar Insulin-United States Market Status and Trend Report 2013-2023 US$ 3,480.00

... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the United States Biosimilar Insulin market as: United States Biosimilar Insulin Market ...

Dec, 2017 151 pages
Biosimilar Insulin-South America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the South America Biosimilar Insulin market as: South America Biosimilar Insulin Market ...

Dec, 2017 158 pages
Biosimilar Insulin-North America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the North America Biosimilar Insulin market as: North America Biosimilar Insulin Market ...

Dec, 2017 154 pages
Biosimilar Insulin-India Market Status and Trend Report 2013-2023 US$ 2,980.00

... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the India Biosimilar Insulin market as: India Biosimilar Insulin Market ...

Dec, 2017 130 pages
Biosimilar Insulin-Global Market Status and Trend Report 2013-2023 US$ 2,480.00

Report Summary Biosimilar Insulin-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilar Insulin industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 158 pages
Biosimilar Insulin-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data US$ 3,680.00

... Biosimilar Insulin-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Biosimilar Insulin industry, standing on the readers’ perspective, delivering detailed market data in Global ...

Dec, 2017 132 pages
Biosimilar Insulin-Europe Market Status and Trend Report 2013-2023 US$ 3,480.00

... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the Europe Biosimilar Insulin market as: Europe Biosimilar Insulin Market ...

Dec, 2017 132 pages
Biosimilar Insulin-EMEA Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Biosimilar Insulin-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilar Insulin industry, standing on the readers’ perspective, delivering detailed market data and ...

Dec, 2017 135 pages
Biosimilar Insulin-China Market Status and Trend Report 2013-2023 US$ 2,980.00

... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the China Biosimilar Insulin market as: China Biosimilar Insulin Market ...

Dec, 2017 132 pages
Biosimilar Insulin-Asia Pacific Market Status and Trend Report 2013-2023 US$ 3,480.00

... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Biosimilar Insulin market as: Asia Pacific Biosimilar Insulin Market ...

Dec, 2017 135 pages
Bevacizumab Biosimilar-United States Market Status and Trend Report 2013-2023 US$ 3,480.00

... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the United States Bevacizumab Biosimilar market as: United ...

Nov, 2017 158 pages
Bevacizumab Biosimilar-South America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the South America Bevacizumab Biosimilar market as: South America Bevacizumab Biosimilar ...

Nov, 2017 160 pages
Bevacizumab Biosimilar-North America Market Status and Trend Report 2013-2023 US$ 3,480.00

... Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the North America Bevacizumab Biosimilar market as: North America Bevacizumab Biosimilar ...

Nov, 2017 135 pages
Bevacizumab Biosimilar-India Market Status and Trend Report 2013-2023 US$ 2,980.00

... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the India Bevacizumab Biosimilar market as: India Bevacizumab ...

Nov, 2017 138 pages
Bevacizumab Biosimilar-Global Market Status and Trend Report 2013-2023 US$ 2,480.00

Report Summary Bevacizumab Biosimilar-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Bevacizumab Biosimilar industry, standing on the readers’ perspective, delivering detailed market data and ...

Nov, 2017 154 pages
Bevacizumab Biosimilar-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data US$ 3,680.00

... Bevacizumab Biosimilar-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Bevacizumab Biosimilar industry, standing on the readers’ perspective, delivering detailed market data in Global ...

Nov, 2017 148 pages
Bevacizumab Biosimilar-Europe Market Status and Trend Report 2013-2023 US$ 3,480.00

... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the Europe Bevacizumab Biosimilar market as: Europe Bevacizumab ...

Nov, 2017 133 pages
Bevacizumab Biosimilar-EMEA Market Status and Trend Report 2013-2023 US$ 3,480.00

Report Summary Bevacizumab Biosimilar-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Bevacizumab Biosimilar industry, standing on the readers’ perspective, delivering detailed market data and ...

Nov, 2017 132 pages
Bevacizumab Biosimilar-China Market Status and Trend Report 2013-2023 US$ 2,980.00

... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the China Bevacizumab Biosimilar market as: China Bevacizumab ...

Nov, 2017 157 pages
Bevacizumab Biosimilar-Asia Pacific Market Status and Trend Report 2013-2023 US$ 3,480.00

... Bevacizumab Biosimilar market Market status and development trend of Bevacizumab Biosimilar by types and applications Cost and profit status of Bevacizumab Biosimilar, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Bevacizumab Biosimilar market as: Asia Pacific ...

Nov, 2017 147 pages
Global Biosimilar Monoclonal Antibodies Market: Trend Analysis and Forecast to 2022 US$ 4,195.00 US$ 3,776.00

... the companies to invest in the biosimilar monoclonal antibodies market. SEGMENTS COVERED: The report segments the global biosimilar monoclonal antibodies market by drug class and by application. The biosimilar monoclonal antibodies market is driven by rituximab and ...

Dec, 2016 100 pages
Commercialisaton of Biosimilars: Multifunctional teamwork for success US$ 2,245.00

... believe companies need to choose 'a road less travelled'? Commercialisation of Biosimilars: Team Tactics & Strategies Across the Product Lifecycle reveals what ... to optimal strategy development and implementation for biosimilars Key insights As the biosimilar market matures, commercial strategies will evolve to ...

Nov, 2017
Biosimilars Real World Evidence: Proving the point US$ 2,245.00

... prices addressed. Real World Data (RWD) and Real World Evidence (RWE) play a key role in building stakeholder confidence and establishing market presence. In Biosimilars Real World Evidence: Proving the point ...

Jul, 2017
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2017 Update US$ 525.00

Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2017 Update The Competitive Intelligence Report „Anti-VEGF & Anti-VEGF-R Biosimilars and Biosuperiors of Avastin ...

Nov, 2017 58 pages
The Future of the U.S. Biologics and Biosimilars Treatment Market for Psoriasis US$ 4,000.00

... with systemic agents. Driven by improved efficacy, the first group of anti TNF treatments led by Enbrel, Humira and Remicade made strong penetration into the psoriasis market. However the emergence of the IL-17 inhibitor class ...

Oct, 2017 104 pages
Japan Biosimilars – A start of Authorized Biosimilar Era? Biosimilar/BioPharma CMO opportunities – JP Conglomerates – A definite role to play for Global Market! US$ 4,000.00

... ~4000) and early entry of the player are critical factors to decide biosimilar penetration and market share dynamics of Japan Biosimilar Market. While ... in next few years for Japan biosimilar players. In this report, we attempt to evaluate key upcoming opportunity for Japan BS market, its competitive landscape, ...

Aug, 2017 128 pages
1 2 3 4 >
Skip to top